BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7527868)

  • 1. [Selective gene therapy of malignant gliomas using brain-specific promoters: its efficacy and basic investigations].
    Shimizu K
    Nihon Rinsho; 1994 Nov; 52(11):3053-8. PubMed ID: 7527868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective expression of foreign genes in glioma cells: use of the mouse myelin basic protein gene promoter to direct toxic gene expression.
    Miyao Y; Shimizu K; Moriuchi S; Yamada M; Nakahira K; Nakajima K; Nakao J; Kuriyama S; Tsujii T; Mikoshiba K
    J Neurosci Res; 1993 Nov; 36(4):472-9. PubMed ID: 7505843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene.
    Tamura K; Tamura M; Ikenaka K; Yoshimatsu T; Miyao Y; Nanmoku K; Shimizu K
    Gene Ther; 2001 Feb; 8(3):215-22. PubMed ID: 11313793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
    Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL
    J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transduction of glioma cells using a high-titer retroviral vector system and their subsequent migration in brain tumors.
    Tamura M; Ikenaka K; Tamura K; Yoshimatsu T; Miyao Y; Kishima H; Mabuchi E; Shimizu K
    Gene Ther; 1998 Dec; 5(12):1698-704. PubMed ID: 10023449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of myelin basic protein gene promoter for the gene therapy of malignant glioma].
    Miyao Y; Shimizu K; Hayakawa T; Mikoshiba K
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2618-23. PubMed ID: 8584710
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene therapy for brain tumors: gene therapy for malignant brain tumors using a retroviral vector accompanied by brain-specific expression of genes].
    Shimizu K; Hayakawa T
    No Shinkei Geka; 1995 Mar; 23(3):189-94. PubMed ID: 7700485
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of glioblastoma by direct inoculation of concentrated high titer-recombinant retrovirus carrying the herpes simplex virus thymidine kinase gene.
    Ikenaka K; Sasaki M; Tamura K; Tamura M; Miyao Y; Nanmoku K; Kawano Y; Nakahira K; Yoshimine T; Shimizu K
    Hum Cell; 2001 Mar; 14(1):49-58. PubMed ID: 11436353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene.
    Ezzeddine ZD; Martuza RL; Platika D; Short MP; Malick A; Choi B; Breakefield XO
    New Biol; 1991 Jun; 3(6):608-14. PubMed ID: 1655012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antitumor gene therapy using suicide genes].
    Berenstein M; Adris S; Ledda F; Wolfmann C; Medina J; Bravo A; Mordoh J; Chernajovsky Y; Podhajcer OL
    Medicina (B Aires); 1998; 58(2):185-8. PubMed ID: 9706253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated gene therapy of experimental gliomas.
    Perez-Cruet MJ; Trask TW; Chen SH; Goodman JC; Woo SL; Grossman RG; Shine HD
    J Neurosci Res; 1994 Nov; 39(4):506-11. PubMed ID: 7884826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oncolytic adenoviral vector carrying the tyrosinase promoter for glioma gene therapy.
    Ulasov IV; Rivera AA; Nettelbeck DM; Rivera LB; Mathis JM; Sonabend AM; Tyler M; Wang M; Douglas JT; Lesniak MS
    Int J Oncol; 2007 Nov; 31(5):1177-85. PubMed ID: 17912445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic liposomes conjugation to recombinant adenoviral vectors containing herpes simplex virus thymidine kinase gene followed by ganciclovir treatment reduces viral antigenicity and maintains antitumor activity in mouse experimental glioma models.
    Mizuno M; Ryuke Y; Yoshida J
    Cancer Gene Ther; 2002 Oct; 9(10):825-9. PubMed ID: 12224023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal brain cells contribute to the bystander effect in suicide gene therapy of malignant glioma.
    Miletic H; Fischer YH; Giroglou T; Rueger MA; Winkeler A; Li H; Himmelreich U; Stenzel W; Jacobs AH; von Laer D
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6761-8. PubMed ID: 18006778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging.
    Maron A; Gustin T; Le Roux A; Mottet I; Dedieu JF; Brion JP; Demeure R; Perricaudet M; Octave JN
    Gene Ther; 1996 Apr; 3(4):315-22. PubMed ID: 8732163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumoral effects of defective herpes simplex virus-mediated transfer of tissue inhibitor of metalloproteinases-2 gene in malignant glioma U87 in vitro: consequences for anti-cancer gene therapy.
    Hoshi M; Harada A; Kawase T; Uyemura K; Yazaki T
    Cancer Gene Ther; 2000 May; 7(5):799-805. PubMed ID: 10830727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.